Radiopharmaceuticals Startup Secures $175M Funding
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
- Latest
- Trending
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Explore AI-driven personalization, autonomous systems, NLP, and ethical challenges shaping AI in 2024.
Biotech firm Eradivir raises $10.25M for Phase 2a EV25 study, aiming to revolutionize influenza treatment.
New study improves voice recognition for dysarthria, aiding Parkinson's patients with communication.
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
Biotech and AI sectors see major funding, with Candid Therapeutics' $370M and Glean's $260M rounds leading the way this week.
Moderna shares dip as R&D spending reduces, focusing on FDA approval for 10 key products including RSV and cancer treatments.
Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.
Explore AI's role in transforming healthcare, finance, transportation, and daily life with key benefits and challenges.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.